Lifecore Biomedical (LFCR) Return on Capital Employed: 2011-2025
Historic Return on Capital Employed for Lifecore Biomedical (LFCR) over the last 13 years, with May 2025 value amounting to -0.08%.
- Lifecore Biomedical's Return on Capital Employed fell 4.00% to -0.08% in Q2 2025 from the same period last year, while for May 2025 it was -0.08%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of -0.08% for FY2025, which is 4.00% down from last year.
- According to the latest figures from Q2 2025, Lifecore Biomedical's Return on Capital Employed is -0.08%, which was up 12.69% from -0.09% recorded in Q1 2025.
- Lifecore Biomedical's 5-year Return on Capital Employed high stood at -0.00% for Q4 2021, and its period low was -0.28% during Q4 2022.
- In the last 3 years, Lifecore Biomedical's Return on Capital Employed had a median value of -0.08% in 2025 and averaged -0.08%.
- Per our database at Business Quant, Lifecore Biomedical's Return on Capital Employed declined by 28bps in 2022 and then rose by 16bps in 2023.
- Quarterly analysis of 5 years shows Lifecore Biomedical's Return on Capital Employed stood at -0.00% in 2021, then declined by 28bps to -0.28% in 2022, then increased by 16bps to -0.11% in 2023, then increased by 6bps to -0.06% in 2024, then decreased by 4bps to -0.08% in 2025.
- Its Return on Capital Employed stands at -0.08% for Q2 2025, versus -0.09% for Q1 2025 and -0.06% for Q4 2024.